Bilasi is a oral solution from Team Pharmaceuticals Ltd., with the generic name Bilastine. It is a non-sedating antihistamine.
There are 82 brands of Bilastine listed in Bangladesh. 53 of them have a lower unit price than Bilasi. The lowest listed price is Blastine 20 mg Tablet at ৳ 10 per unit.
What is Bilasi 12.5 mg/5 ml Oral Solution?
Bilasi 12.5 mg/5 ml oral solution is a medicine made by Team Pharmaceuticals Ltd. Like any medicine, it should be used only as advised by a doctor, who will decide whether it is appropriate for you and how it should be taken. Histamine is a substance the body releases during allergic reactions, causing sneezing, itching, watery eyes and hives. The doctor decides whether it is suitable for you and how it should be taken.
Uses of Bilasi
It is a non-sedating antihistamine. Bilasi is used for the symptomatic treatment of allergic rhino-conjunctivitis, which may be seasonal or perennial, and of urticaria. The medicine helps relieve symptoms linked to these allergic reactions. Ask your doctor whether it is right for your condition.
How to use Bilasi
Swallow the oral solution as advised. Do not change the dose or stop early without asking your doctor. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Bilasi
Anyone who notices a side effect or feels unwell while taking Bilasi should tell their doctor or pharmacist, especially if it continues or worries them. In clinical trials, the most commonly reported side effects were headache, dizziness, somnolence and fatigue, and these occurred with a frequency comparable to placebo. Contact the doctor if a side effect is troublesome, does not go away, or if your child seems unwell. Contact your doctor promptly if a side effect worries you, does not settle, or seems to be getting worse. Tell your doctor if you notice any of these or any other unusual effect.
Safety and precautions
There are no or limited amount of data from the use of Bilastine in pregnant women. Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, parturition or postnatal development. Ask your doctor first if any of these apply to you.
Frequently asked questions
What does Bilasi treat?
It is a non-sedating antihistamine. Bilasi is used for the symptomatic treatment of allergic rhino-conjunctivitis, which may be seasonal or perennial, and of urticaria.
How do I use Bilasi correctly?
Swallow the oral solution as advised. Do not change the dose or stop early without asking your doctor.
Can Bilasi cause side effects?
Anyone who notices a side effect or feels unwell while taking Bilasi should tell their doctor or pharmacist, especially if it continues or worries them. In clinical trials, the most commonly reported side effects were headache, dizziness, somnolence and fatigue, and these occurred with a frequency comparable to placebo.
Bilastine is indicated for symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.
Pharmacology
Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral H 1 receptor antagonist affinity and no affinity for muscarinic receptors. Bilastine inhibits histamine-induced wheal and flare skin reactions for 24 hours following single doses.
Dosage & Administration
Adults & adolescents (12 years of age and over): 20 mg tablet once daily for symptomatic relief of allergic rhinitis, urticaria and allergic rhinoconjunctivitis. The maximum recommended daily dose is 20 mg Bilastine (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken. 20 mg Bilastine tablet (1 tablet) once daily should be swallowed with water on an empty stomach to achieve optimal exposure to Bilastine.
Children between 6 to 11 years: 10 mg mouth dissolving tablet for the symptomatic relief of allergic rhinitis, allergic rhinoconjunctivitis and urticaria. The Mouth dissolving tablet is for oral use only. It should be placed in the mouth. It will disperse rapidly in saliva and can be easily swallowed. Alternatively, the mouth dissolving tablet can be dispersed in a tea spoon of water before being swallowed by the children. The maximum recommended daily dose for children in between 6 to 11 years is 10 mg Bilastine mouth dissolving tablet (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken.
Children between 2 to 11 years: 4 ml once daily.
Interaction
Concomitant intake of Bilastine and Ketoconazole or Erythromycin or Diltiazem increased C max of Bilastine. The psychomotor performance after concomitant intake of alcohol and Bilastine was similar to that observed after intake of alcohol and placebo. Concomitant intake of Bilastine and Lorazepam 3 mg for 8 days did not potentiate the depressant CNS effects of Lorazepam.
Contraindications
Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet.
Side Effects
The most commonly reported side effects in clinical trial are headache, dizziness, somnolence and fatigue. These adverse events occurred with a comparable frequency in patients receiving placebo.
Pregnancy & Lactation
There are no or limited amount of data from the use of Bilastine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, parturition or postnatal development. As a precautionary measure, it is preferable to avoid the use of Bilastine during pregnancy. The excretion of Bilastine in milk has not been studied in humans. A decision must be made taking into account the benefit of breast-feeding for the child and the benefit of Bilastine therapy for the mother.
Precautions & Warnings
Co-administration of Bilastine and P-glycoprotein inhibitors (e.g. Ketoconazole, Erythromycin, Cyclosporine, Ritonavir or Diltiazem) should be avoided in patients with moderate or severe renal impairment.
Overdose Effects
In clinical trials, after administration of Bilastine at doses 10 to 11 times the therapeutic dose (220 mg as single dose; or 200 mg/day for 7 days) frequency of treatment-emergent adverse events was two times higher than with placebo. The adverse reactions most frequently reported were dizziness, headache and nausea. No serious adverse events and no significant prolongation in the QTc interval were reported.
Storage Conditions
Keep below 30°C temperature, protected from light and moisture. Keep out of reach of children.
Alternative brands of Bilastine
Other brands with the same generic name, cheapest first.